COCP vs QRVO · rev $105.0K vs P/E 27, rev $3.68B
Cocrystal Pharma Inc (COCP) versus Qorvo Inc (QRVO) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
COCP currently screens at market cap $13.3M. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Not investment advice. Open the COCP and QRVO stock pages for the full models.
Not investment advice.